The US Food and Drug Administration (FDA) recently issued a final rule altering how the labels for physicians on prescription drugs and biological products provide information for pregnant and breastfeeding women.
In an exclusive interview with Charles J. Lockwood, MD, MHCM, senior vice president, University of South Florida (USF) Health, and dean, USF Health Morsani College of Medicine, Tampa, we asked what steps physicians can take to impact the sobering statistic of 1 in 9 US infants still being born at 37 or fewer weeks.
A panel of experts were bested only once at the “Stump the Professors” session at the 43rd AAGL Global Congress on Minimally Invasive Gynecology in Vancouver. A sarcoma was the diagnosis that got away among three complex cases presented to a packed audience.
Women who receive the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) may not be at increased risk of preterm birth or other adverse birth outcomes, according to a new study in JAMA.
A small study by investigators from Harvard University suggests that cryopreserved embryo transfer (CET) is a strong independent risk factor for placenta accreta in women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).